J&J Unit Targets Haupt, Ranbaxy Birth Control Generics
Janssen Pharmaceuticals Inc., sued Germany-based Haupt Pharma AG's U.S. unit, Haupt Pharma Inc., as well as India-based Ranbaxy Laboratories Ltd. and its New Jersey-based unit, Ranbaxy Laboratories Inc.
Janssen alleges the generics makers filed abbreviated new drug applications with the U.S. Food and Drug Administration to produce and sell versions of...
Already a subscriber? Click here to login